Liquid fructose downregulates Sirt1 expression and activity and impairs the oxidation of fatty acids in rat and human liver cells

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1841, Issue 4, 2014, Pages 514-524

  Rebollo, Alba ^a   Roglans, Núria ^a,b   Baena, Miguel ^a,b   Sánchez, Rosa M ^a,b   Merlos, Manel ^a,b   Alegret, Marta ^a,b   Laguna, Juan C ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

ChREBP; PPAR ; Steatosis; Triglyceride

Indexed keywords

FATTY ACID; FRUCTOSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHOPROTEIN PHOSPHATASE 2A; SIRTUIN 1; SIRT1 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REGULATION; FATTY ACID OXIDATION; FEMALE; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; NONHUMAN; OSMOTIC STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; LIVER; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY;

ANIMALS; FATTY ACIDS; FRUCTOSE; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; LIVER; OXIDATION-REDUCTION; PPAR ALPHA; RATS; SIRTUIN 1;

EID: 84896824742     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2014.01.002     Document Type: Article

References (43)

1. F.B. Hu, and V.S. Malik Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence Physiol. Behav. 100 2010 47 54
2. E. Fabbrini, S. Sullivan, and S. Klein Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications Hepatology 51 2010 679 689
3. D. Preiss, and N. Sattar Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence Clin. Endocrinol. 70 2009 815 828
4. M.A. Pereira The possible role of sugar-sweetened beverages in obesity etiology: a review of the evidence Int. J. Obes. 30 2006 S28 S36
5. V.S. Malik, B.M. Popkin, G.A. Bray, J.-P. Després, and F.B. Hu Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk Circulation 121 2010 1356 1364
6. M.K. Hellerstein Carbohydrate-induced hypertriglyceridemia: modifying factors and implications for cardiovascular risk Curr. Opin. Lipidol. 13 2002 33 40 (Pubitemid 34174627)
7. J.S. Lim, M. Mietus-Snyder, A. Valente, J.-M. Schwartz, and R.H. Lustig The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome Nat. Rev. Gastroenterol. Hepatol. 7 2010 251 264
8. G.N. Prager, and J.A. Ontko Direct effects of fructose metabolism on fatty acid oxidation in a recombined rat liver mitochondria-high speed supernatant system Biochim. Biophys. Acta 424 1976 386 395
9. N. Roglans, L. Vilà, M. Alegret, R.M. Sánchez, M. Vázquez-Carrera, and J.C. Laguna Impairment of hepatic STAT-3 activation and reduction of PPARα activity in fructose-fed rats Hepatology 45 2007 778 788 (Pubitemid 46450629)
10. L. Vila, N. Roglans, M. Alegret, R.M. Sánchez, M. Vázquez-Carrera, and J.C. Laguna Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism Hepatology 48 2008 1506 1516
11. K. Ravnskjaer, M. Boergesen, L.T. Dalgaard, and S. Mandrup Glucose-induced repression of PPARalpha gene expression in pancreatic beta-cells involves PP2A activation and AMPK inactivation J. Mol. Endocrinol. 36 2006 289 299
12. S. Lavu, O. Boss, P.J. Elliott, and P.D. Lambert Sirtuins - novel therapeutic targets to treat age-associated diseases Nat. Rev. Drug Discov. 7 2008 841 853
13. J.T. Rodgers, C. Lerin, Z. Gerhart-Hines, and P. Puigserver Metabolic adaptations through the PGC-1α and SIRT1 pathways FEBS Lett. 582 2008 46 53 (Pubitemid 350297246)
14. J.N. Feige, M. Lagouge, C. Canto, A. Strehle, S.M. Houten, J.C. Milne, P.D. Lambert, C. Mataki, P.J. Elliott, and J. Auwerx Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation Cell Metab. 8 2008 347 358
15. M. Helenius, M. Hänninen, S.K. Lehtinen, and A. Salminen Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NFκB transcription factor in mouse cardiac muscle J. Mol. Cell. Cardiol. 28 1996 487 498
16. M.M. Bradford A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding Anal. Biochem. 1976 248 254
17. N. Roglans, E. Sanguino, C. Peris, M. Alegret, M. Vázquez, T. Adzet, C. Díaz, G. Hernandez, J.C. Laguna, and R.M. Sánchez Atorvastatin treatment induced peroxisome proliferator-activated receptor α expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats J. Pharmacol. Exp. Ther. 2002 232 239 (Pubitemid 34680443)
18. P.B. Lazarow Assay of peroxisomal ß-oxidation of fatty acids Methods Enzymol. 72 1981 315 319
19. A. Planavila, J.C. Laguna, and M. Vázquez-Carrera Nuclear factor kappa B activation leads to down regulation of fatty acid oxidation during cardiac hypertrophy J. Biol. Chem. 280 2005 17464 17471 (Pubitemid 41389218)
20. L. Vila, N. Roglans, V. Perna, R.M. Sánchez, M. Vázquez-Carrera, M. Alegret, and J.C. Laguna Liver AMP/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructose J. Nutr. Biochem. 22 2011 741 751
21. K. Uyeda, and J.J. Repa Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis Cell Metab. 4 2006 107 110 (Pubitemid 44138720)
22. S.Y. Kim, H.I. Kim, T.H. Kim, S.S. Im, S.K. Park, I.K. Lee, K.S. Kim, and Y.H. Ahn SREBP-1c mediates the insulin dependent hepatic glucokinase expression J. Biol. Chem. 279 2004 30823 30829
23. T. Leone, C.J. Weinheimer, and D.P. Kelly A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: the PPARα-null mouse as a model of fatty acid oxidation disorders Proc. Natl. Acad. Sci. U. S. A. 96 1999 7473 7478 (Pubitemid 29299686)
24. S.-H. Koo, H. Satoh, S. Herzig, C.-H. Lee, S. Hedrick, R. Kulkarni, R.M. Evans, J. Olefsky, and M. Montminy PGC-1 promotes insulin resistance in liver through PPAR-α - dependent induction of TRB-3 Nat. Med. 10 2004 530 534 (Pubitemid 38667913)
25. M. Yoon The role of PPARα in lipid metabolism and obesity: focusing on the effects of estrogen on PPARα actions Pharmacol. Res. 60 2009 151 159
26. M. Schreurs, F. Kuipers, and F.R. van der Leij Regulatory enzymes of mitochondrial β-oxidation as targets for treatment of the metabolic syndrome Obes. Rev. 11 2010 380 388
27. V. Pashkov, J. Huang, V.K. Parameswara, W. Kedzierski, D.M. Kurrasch, G.G. Tall, V. Esser, R.D. Gerard, K. Uyeda, H.C. Towle, and T.M. Wilkie Regulator of G protein signaling (RGS16) inhibits hepatic fatty acid oxidation in a carbohydrate response element-binding protein (ChREBP)-dependent manner J. Biol. Chem. 286 2011 15116 15125
28. M. Hamblin, L. Chang, Y. Fan, J. Zhang, and Y.E. Chen PPARs and the cardiovascular system Antioxid. Redox Signal. 11 2009 1415 1452
29. R.T. Boudreau, and D.W. Hoskin The use of okadaic acid to elucidate the intracellular role(s) of protein phosphatase 2A: lessons from the mast cell model system Int. Immunopharmacol. 5 2005 1507 1518 (Pubitemid 40967908)
30. J.-F. Louet, G. Hayhurst, F.J. Gonzalez, J. Girard, and J.-F. Decaux The coactivator PGC-1 is involved in the regulation of the liver carnitine palmiotyltransferase I gene expression by cAMP in combination with HNF4α and cAMP-response element-binding protein (CREB) J. Biol. Chem. 277 2002 37991 38000 (Pubitemid 35154650)
31. H. Wang, and C.B. Wollheim Does chasing selected "Fox" to the nucleus prevent diabetes? Trends Mol. Med. 11 2005 262 265 (Pubitemid 40804788)
32. J.C. Milne, P.D. Lambert, S. Schenk, D.P. Carney, J.J. Smith, D.J. Gagne, L. Jin, O. Boss, R.B. Perni, C.B. Vu, J.E. Bemis, R. Xie, J.S. Disch, P.Y. Ng, J.J. Nunes, A.V. Lynch, H. Yang, H. Galonek, K. Israelian, W. Choy, A. Iffland, S. Lavu, O. Medvedik, D.A. Sinclair, J.M. Olefsky, M.R. Jirousek, P.J. Elliott, and C.H. Westphal Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes Nature 450 2007 712 716 (Pubitemid 350207685)
33. X. Hou, S. Xu, K.A. Maitland-Toolan, K. Sato, B. Jiang, Y. Ido, F. Lan, K. Walsh, M. Wierzbicki, T.J. Verberuren, R.A. Cohen, and M. Zang SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase J. Biol. Chem. 283 2008 20015 20026
34. C. Cantó, Z. Gerhart-Hines, J.N. Feige, M. Lagouge, L. Noriega, J.C. Milne, P.J. Elliott, P. Puigserver, and J. Auwerx AMPK regulates energy expenditure by modulating NAD + metabolism and SIRT1 activity Nature 458 2009 1056 1060
35. B.N. Finck, and D.P. Kelly Peroxisome proliferator-activated receptor γ coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease Circulation 115 2007 2540 2548 (Pubitemid 46763228)
36. A. Purushotham, T.T. Schug, Q. Xu, S. Surapureddi, X. Guo, and X. Li Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation Cell Metab. 9 2009 327 338
37. N. Daly-Youcef, M. Lagouge, S. Froelich, C. Koehl, K. Schoojans, and J. Auwerx Sirtuins: the "magnificent seven", function, metabolism and longevity Ann. Med. 39 2007 335 345
38. R. Dentin, L. Tomas-Cobos, F. Foufelle, J. Leopold, J. Girard, C. Postic, and P. Ferre Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver J. Hepatol. 56 2012 199 209
39. M. Boergesen, L. la Cour Poulsen, S. Fisker Schmidt, F. Frigerio, P. Maechler, and S. Mandrup ChREBP mediated glucose repression of peroxisome proliferator-activated receptor α expression in pancreatic β-cells J. Biol. Chem. 286 2011 13214 13225
40. L.G. Noriega, J.N. Feige, C. Cantó, H. Yamamoto, J. Yu, M.A. Herman, C. Mataki, B.B. Kahn, and J. Auwerx CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability EMBO Rep. 12 2011 1069 1076
41. R.H. Wang, C. Li, and C.X. Deng Liver steatosis and increased ChREBP expression in mice carrying a liver specific SIRT1 null mutation under a normal feeding condition Int. J. Biol. Sci. 6 2010 682 690
42. J. Bricambert, J. Miranda, F. Benhamed, J. Girard, C. Postic, and R. Dentin Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice J. Clin. Invest. 120 2010 4316 4331
43. A. Abde-Sayed, C. Binnert, K.A. Le, M. Bortolotti, P. Schneiter, and A. Tappy A high-fructose diet impairs basal and stress-mediated lipid metabolism in healthy male subjects Br. J. Nutr. 100 2008 393 399